Literature DB >> 3133806

Effect of 4-hydroxy-2,3-trans-nonenal on platelet function.

M L Selley1, J A McGuiness, L A Jenkin, M R Bartlett, N G Ardlie.   

Abstract

4-Hydroxy-2,3-trans-nonenal (HNE), an aldehyde end-product of lipid peroxidation, potentiated aggregation and increased thromboxane A2 formation in platelets challenged with ADP, thrombin or the ionophore A23187. These effects were observed at HNE concentrations in the range 10-100 microM. Platelet responses to collagen, epinephrine and arachidonic acid were not affected by HNE. Concentrations of HNE in excess of 100 microM inhibited platelet activation. HNE increased the release of 3H-arachidonic acid from prelabelled platelet phospholipids in response to thrombin or ADP. It is proposed that HNE may play an important role in controlling platelet function by regulating the activity of phospholipase A2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133806

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Modification of platelet proteins by 4-hydroxynonenal: Potential Mechanisms for inhibition of aggregation and metabolism.

Authors:  Saranya Ravi; Michelle S Johnson; Balu K Chacko; Philip A Kramer; Hirotaka Sawada; Morgan L Locy; Landon S Wilson; Stephen Barnes; Marisa B Marques; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2015-10-22       Impact factor: 7.376

2.  Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis.

Authors:  M L Selley; D J Bourne; M R Bartlett; K E Tymms; A S Brook; A M Duffield; N G Ardlie
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  Association of aspirin resistance with 4-hydroxynonenal and its impact on recurrent cerebral infarction in patients with acute cerebral infarction.

Authors:  Juan Guo; Jue Wang; Yanxia Guo; Juan Feng
Journal:  Brain Behav       Date:  2020-02-06       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.